ascopubs.org

Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia Our study demonstrated that ...
The Australian Financial Review

RHG appeases shareholders

John Kinghorn ’s RHG has resolved to make its first dividend payment after the emphatic rejection of the company’s buyback proposal by shareholders yesterday. Management of the former non-bank lender, ...
The Australian

Rival bid in RHG pursuit

Pepper, which typically provides low-doc loans, yesterday unveiled an offer of 46c a share for RHG, which it claimed was "superior" to a bid by rival non-bank Resimac and dealmaker Trevor Loewensohn.
The Australian Financial Review

RHG opens books to Resimac

Listed mortgage company RHG, formally RAMS Mortgage Corp, has engaged with suitor Resimac and opened the door to a period of due diligence on the $128 million proposal. RHG has executed ...
ascopubs.org

Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia We conducted a phase II, ...